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Translational research data are generated in multiple research domains from the bedside to experimental
laboratories. These data are typically stored in heterogeneous databases, held by segregated research
domains, and described with inconsistent terminologies. Such inconsistency and fragmentation of data
signiﬁcantly impedes the efﬁciency of tracking and analyzing human-centered records. To address this
problem, we have developed a data repository and management system named TraM (http://tram.uchi-
cago.edu), based on a domain ontology integrated entity relationship model. The TraM system has the
ﬂexibility to recruit dynamically evolving domain concepts and the ability to support data integration
for a broad range of translational research. The web-based application interfaces of TraM allow curators
to improve data quality and provide robust and user-friendly cross-domain query functions. In its current
stage, TraM relies on a semi-automated mechanism to standardize and restructure source data for data
integration and thus does not support real-time data application.
 2008 Elsevier Inc. All rights reserved.1. Introduction
With completion of the human genome project, scientists are
systematically studying the molecular basis of human diseases
[1–3] to explore effective individualized therapies [4–7]. To
achieve this unprecedented goal, investigators are breaking tradi-
tional boundaries between research domains from patient bed-
sides to experimental laboratories to conduct translational
research [7–8]. Data generated from research on different topics
need to be extensively reviewed and iteratively veriﬁed to become
reliable clinical or scientiﬁc knowledge [9–10]. However, because
the majority of clinical and basic research data are currently stored
in disparate and separate domain databases, it is often inefﬁcient
for a researcher to access these data [11–14]. Furthermore, even
where domain data can be aggregated and viewed through a single
computational platform, translational researchers still often see
incomplete, fragmented, and unveriﬁed data in their original
forms. These problems greatly impede research efﬁciency, particu-
larly statistical analysis. Despite overwhelming demands for a
modern method to facilitate personalized data tracking, manage-
ment, and improvement over a translational workﬂow, few soft-ll rights reserved.
ormatics Core, Computation
oom 334, Chicago, IL 60637,
34 (O.I. Olopade).
g), folopade@medicine.bsd.u-ware products that meet these requests are available or widely
accepted in the translational research community.
Our goal was to provide a computational system that is able
to: (1) integrate data generated from multiple research domains
with the ﬂexibility to capture dynamically evolving domain con-
cepts; (2) allow curation for data improvement; (3) support ro-
bust and intuitive query functions for biomedical researchers;
(4) execute independently from third party products, meaning
the system does not have to rely on a direct interaction with
source databases (SDBs) or any middleware for its stable perfor-
mance; and (5) be generic enough that it can be applied to a
broad range of translational research. Achieving these goals en-
ables our system to answer important questions that involve data
generated in multiple research domains. For example, a transla-
tional researcher may ask: (1) How many patients, who were
diagnosed with cancer ‘‘A” and had pathology records available,
share a genetic proﬁle ‘‘B”? (2) Which patients who have a special
histological cancer type ‘‘C” and under a special treatment ‘‘D”
share a distinct biomarker ‘‘E” and a unique family and exposure
history? (3) Do these patients have tissue or DNA samples avail-
able and where can these samples be obtained for further
studies?
Our system, the Translational Data Mart (TraM), was developed
upon a domain ontology (DO) [15] integrated entity relationship
model (ERM) [16,17] and it has been implemented and in use by
several translational researchers. Later in the Section 6 of this
paper, we will describe how the TraM system is applied in the real
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offer to answer important research questions.
2. Terminology used in this paper
Domain data integritymeans the data are ‘‘whole” or ‘‘complete”
according to required information standards set by a particular re-
search domain. For example, microarray data must meet the stan-
dards of Minimum Information About a Microarray Experiment
(MIAME) as deﬁned by the functional genomics research domain
[18].
Translational integritymeans that the data completionmeets the
minimal required standards as deﬁned by a translational research
plan, which may include data from multiple research domains. Do-
main data integrity does not automatically yield translational
integrity.
Translational continuity refers to a special data completion sta-
tus that allows one to track a single person’s data from one re-
search domain to another over a translational workﬂow.
A data element (DE) is an atomic element within a database. It is
equivalent to an attribute in an ERM [16]. A DE is composed of two
function domains: a concept domain that holds the abstract name
for a set of data that share the same concept and a value domain
that carries the records belonging to this concept. For example,
‘‘dosage” is a concept, ‘‘15” is a value, ‘‘unit of measure” is a con-
cept, and ‘‘mg/day” is a value.
Translational element (TE) denotes primary identiﬁers of related
domain databases that are mapped to each other and stored within
the databases. For example, when the barcode of a tissue sample
(originating from a tissue bank database) is mapped to the medical
record number (collected from a clinical database) of a person from
whom the sample is derived, we say that the medical record num-
ber and barcode are TEs of each other. TEs are the DE to assure
translational integrity and continuity. If missing, TEs can be recov-
ered by using other critical DEs stored in both SDBs, such as name,
date of birth, race, and gender.
Data aggregation vs. data integration: data aggregation is the col-
lective display of data in a uniﬁed platform, or physical collection
of data within a centralized storage system from separated sources.
Aggregated data may or may not relate to each other. Data integra-
tion is a special type of data aggregation that requires that aggre-
gated data share TEs.
Personalized data are the data that can be identiﬁed as being
associated with a distinct person, no matter how distant the data
origin or derivatives are.3. Background
3.1. Translational data status and domain database systems
The challenge of integrating source data from various research
domains comes from the nature of translational workﬂows and
the conditions of domain databases. In reality, one domain may
contain zero, one, or more databases. Different databases designed
for the same purpose may have distinct data structures. A database
may have multiple versions and each version often results in a set
of data that do not share the same data structure with others. The
heterogeneity in concept extraction, data modeling, logical inter-
pretation, naming convention, DE conﬁguration, vocabulary used,
and format deﬁnition all contribute to the challenge of data inte-
gration [19,20]. In addition, if SDBs are not designed to store TEs
from other domain databases, the connections among these source
data will be disrupted, even though domain data integrity within
these SDBs might have been achieved. Furthermore, logically con-
secutive SDBs in a translational workﬂow often recruit biomedicalrecords in an autonomously administrative manner. If these dat-
abases recruit data from unrelated cohorts, personalized data ﬂow
can be truncated without being noticed [21]. These problems all
lead to one unwanted consequence: data are inconsistent in their
structure and expressions and discontinued in their cross-domain
connections. Data in such condition cannot be effectively compre-
hended and used without thorough cleansing, recovery, reconﬁgu-
ration, and reorganization.
3.2. Data organization architectures for data integration
Several methods have been proposed to address the problems
associated with integrating biomedical data. These methods in-
clude semantic mapping [22], ontology and agent methods [23],
service-oriented architectures or grids [24–26], distributed search
engines [27–29], and federated databases and data warehouse
[19,20]. For those interoperable data sharing methods, e.g., ser-
vice-oriented grids, distributed search engines, and federated dat-
abases, the availability of a service-enabled infrastructure is
essential. This kind of infrastructure has not yet been established
or standardized in most medical institutions. The majority of
Health Insurance Portability and Accountability Act (HIPAA)-com-
pliant SDBs are proprietary products and many have neither native
web-services nor an accessible application programming interface
(API), which makes immediate interoperable data extraction plan
not feasible. Even if many SDBs are service-enabled, which
undoubtedly will greatly enhance data aggregation ability from
disparate sources, translational integrity and continuity will not
be automatically achieved simply because of improved interopera-
bility. Thorough data cleansing and veriﬁcation process is likely re-
quired before data can be truly integrated and effectively used
[20,23]. Furthermore, it will take a tremendous effort and time to
make every required SDB in a translational research plan service-
enabled. If one of these SDBs happens to be not interoperable,
the data held within this SDB have to ﬁnd other ways to be
extracted and integrated. On the other hand, semantic mapping
service has been developed to improve data standardization efﬁ-
ciency [22,26]. However, it alone may not be sufﬁcient to resolve
deeper problems caused by the divergence of data modeling
methods.
It is generally agreed that no single data integration architec-
ture can satisfy all demands of the entire biomedical research com-
munity. For the goals we intend to achieve, in particular to improve
translational data integrity and continuity, data warehouse and
federated databases are most appealing [19,20] . The two
approaches are based upon entirely different design theories and
result in distinct system architectures. Each of them has its
strengths and limitations. Table 1 (modiﬁed from Louie et al.
[20]) compares the two systems noting issues speciﬁc to transla-
tional research. For both architectures, the challenge of achieving
broad system adaptability in different SDBs environments is
daunting, although the coping methods are different. We believe
that the heterogeneity of SDB architectures and segregation of do-
main database managements in different institutions will have a
larger impact on federated databases than on data warehouses.
Data warehouse architecture is a stand-alone system, and only
access to source data is required for its basic function.
3.3. Data integration methods
Data integration methods are classiﬁed into three subtypes
[19,23]: (i) information linkage, (ii) query translation, and (iii) data
translation. Information linkage uses a URL to access data in an
HTML form presented by other computation platforms through
the Internet [23]. Query translation is meant to convert source data
on the ﬂy and present data via a virtual data organization structure
Table 1
Data integration system comparison for translational data
Architecture Requirement Advantages Disadvantages Applications
Data warehouse Source data Excellent query
performance;
allow curation;
support data
cleansing
Limited data coverage; not real-time data;
extra data copy; inconsistent data copy
between SDB and warehouse
Streamlined data; high-quality data; curation
required; personalized translational continuity
required; real-time data not required; global
range detailed data not required
Federated DB Transparent SDB and
network architecture;
accessibility to API of
constituent SDBs
Updated or real-
time data; ﬂexible
data coverage; no
extra data copy
Little data cleansing; infrastructure
dependency; performance may be
affected by constituent SDBs; not easy to
achieve the continuity of personalized
data across research domains
View data as they exist; real-time data
required; global range all data coverage
preferred; ‘‘write” permission not required;
personalized translational continuity not
required
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does not require physically storing an extra copy of data. Therefore
data always stay in their original form in the SDBs. Data translation
is often associated with a data warehouse method. The end prod-
uct of this approach is a physical copy of data that may not be pre-
sented or organized the same way as they were in their original
storage systems [19,20]. This method, together with data ware-
house architecture, seems somewhat under-appreciated in discus-
sions on biomedical data integration technology [19,22,26].
However, they have been suggested to be more suitable for inte-
grating clinical and human genetic proﬁle data [20,23].
From our day-to-day experiences dealing with various transla-
tional data, we have found that preprocessing translational raw
data requires considerable knowledge of research subjects in order
to obtain reliable information. Therefore, in addition to automated
data translation procedures, human intervention is required to as-
sure data reliability. A data warehouse solution supports a uniﬁed
platform for further data curation. Curating integrated data is not
new in biomedical data management. Many public biomedical dat-
abases [30–35] have been subject to, and are continuously under-
going, expert-assisted curation.
4. Methods
After carefully comparing the advantages and disadvantages of
the major system architectures for our intended goals (Table 1,
Section 3.2), we decided to use data warehouse architecture as
our data storage method. To design a data warehouse that can sus-
tain the progress of translational research, we must ﬁrst dissect
translational data in order to understand the fundamentals under-
lying their enormous complexity.
4.1. Anatomy of translational data
A typical translational data point can be placed in a three
dimensional space (Fig. 1A). The ﬁrst dimension (x-axis) comprises
the material objects coming from human subjects. They are the re-
search objects in a translational study. In this dimension, each de-
rived object inherits all the characteristics from the upper level
object, and passes on its own characteristics to its derivatives.
The integrity of the object transition in this dimension lays the
foundation for translational continuity. The second dimension
(y-axis) represents the concepts of scientiﬁc knowledge in various
research domains. Each domain independently exists and is ruled
by its internal logic. The associations between these domains only
occur when they have conducted research on the objects from the
same individual. The third dimension (z-axis) is temporal, which is
clearly important for tracking the status of any ongoing project.
Therefore, a typical translational data point always contains three
essential elements: a domain concept, a research object, and a time
stamp. This model does not explicitly display names and physicallocations of research facilities, as they are emphasized in a clinical
data model [36].
A global view of dataﬂow (Fig. 1B) illustrates the assembled
translational data points described above. It further reveals the
translational logic that deﬁnes the relationship between research
domains and research objects, e.g., a mammogram is applied to a
person while genotyping to a DNA sample. When the integrity of
research objects is achieved, the possibility of translational conti-
nuity is established.
4.2. Data modeling
4.2.1. The conceptual data model
The rationale underlying the conceptual data model is the anal-
ysis of translational data anatomy described in Fig. 1 (Section 4.1).
The backbone structure of the TraM data warehouse is an ERM [16]
that extracts data entities from a translational workﬂow and con-
structs the relationships between these entities. A highly simpli-
ﬁed ER diagram is outlined in Fig. 2A: Research object entities,
corresponding to the x-axis of Fig. 1A, are in ‘‘one-to-many” rela-
tions that cascade from a person object to the samples derived
from this person. These objects and research domains (y-axis of
Fig. 1A) are generally in ‘‘many-to-many” relations presented in
diamond shapes in Fig. 2A. Each of these relationships corresponds
to a set of three dimensional data points summarized in Fig. 1A, and
contains a time stamp indicated in z-axis of Fig. 1A as an attribute
(e.g., a diagnosis date or a treatment date). There are no direct rela-
tionships between research domains, unless they are associated
with research objects from the same origin described in
Fig. 1B.
4.2.2. The logical data model
Often in data modeling, the logical design process of deﬁning
attributes to entities reshapes the concept model because it makes
us rethink the correctness of earlier conceptual design. An example
of these recurrent activities is the integration of domain ontology
(DO) [15] into the TraM ERM backbone structure (Fig. 2). Ongoing
scientiﬁc inquiries often produce new concepts and/or classes of
new concepts dynamically. At the rudimentary stage, these con-
cepts are usually not well classiﬁed. In order to efﬁciently recruit
these concepts and the data generated under these concepts, we
need a more ﬂexible data structure able to capture these concepts
and data in controlled vocabulary without disturbing the database
architecture. Domain ontology suits this demand well and is fully
supported by ERM technology [17]. A DO structure supports con-
cept classiﬁcation and treats concepts as data, but a DO alone does
not accommodate many-to-many relationships. Therefore, it is not
suitable for connecting research objects (person, specimen and
sample) to research data. Furthermore, the hierarchy of a DO can
not connect to the other DOs without higher order ontology
[15,37]. The purpose of TraM is not for integrating DOs per se.
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104 X. Wang et al. / Journal of Biomedical Informatics 42 (2009) 100–112Instead, its goal is to integrate domain data. These data may belong
to the concepts classiﬁed in a DO. The solution is to establish a
many-to-many relationship between the leaf class of a DO and a re-
search object, to create new domain concepts and to integrate new
domain data instantaneously.
To illustrate how a DO can play an important role in a trans-
lational data integration system, consider medical demographic
survey data, one of the least standardized and structured data-
sets in translational research. It is not uncommon to see the
same survey concept (i.e., question) worded differently in several
questionnaires and to have the data value (i.e., answer) to the
same question expressed in a variety ways. The number of sur-
vey questions for a survey subject varies from fewer than ten
to hundreds. Survey subject matter changes as research interest
shifts, and no one can really be certain whether a new question
will emerge and what the question will look like. Therefore, little
database support exists for this ﬂuctuation in data and some
authors suggest such data do not belong in the clinical concep-
tual data model [36]. In reality, many survey results remain on
paper or in locally-designed ACCESS databases. These databases
often treat a survey question as an attribute (a column). Thus,
adding, removing, or changing any question will cause a change
in table structure, so that we often see multiple versions of a
database for the same purpose, and each version contains similar
survey data in different organizations and descriptions. As a con-
sequence, it is extremely difﬁcult to align the survey results and
integrate them with other domain data, despite the fact that they
routinely need to be integrated with other clinical records for a
translational research plan.Questionnaire 
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tionnaire itself. The subclass (category), which can be one or more
layers, classiﬁes a general concept for a set of real questions, such
as dietary habit or history of hormone replacement therapy. The
question item is the leaf class of this ontology. Each item contains
a set of attributes for a real question, such as ‘‘what”, ‘‘when”,
‘‘how” and ‘‘why”, etc. Accordingly, each of these questions also
has a set of properties that deﬁne an answer, such as data type
(number or text), unit of measure (cup/day, pack/day, ug/ml)
and predeﬁned answer options. In this model, a new question
and its properties are treated as a new record (a new row in
question item table). Thus, the overall data structure stays the
same even if a new survey question is added to the system. Each
selected answer during a survey is previously deﬁned in con-
trolled vocabulary when building the ontology. This answer will
be recorded in a relationship between a person entity and a ques-
tion item entity, so the survey results are seamlessly integrated
with other domain data.
4.2.3. The physical data model
The process of ﬁnalizing the physical design of the TraM
model is focused on DE conﬁgurations (attribute names, data
type and formats) and constraint classiﬁcations. Instead of mir-
roring the DE conﬁgurations from SDBs, we make decisions
based upon our analysis on the nature of source data, regardless
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agreement over data modeling at both conceptual and logical
levels. For example, the deﬁnition and conﬁguration of DEs can
be very different when the same data content is restructured
from a one-to-many relationship to a many-to-many relationship
[16].
4.3. Data integration workﬂow
Two kinds of data integration methods are used for the TraM
data integration. The information linkage method (via URL) [23]
is used to connect the data in the public domain for biological con-
cept adoption and reference information, as we do not see the
necessity to restructure or represent these data.
The data translation method [19,23] is used to aggregate indi-
viduals’ data from private and domain SDBs into TraM. A typical
data translation workﬂow contains procedures for data concept
extraction, data model conversion, data element reconﬁguration,
semantic mapping, data matrix reorganization, and data stan-
dardization. The entire process is illustrated in Fig. 3 in which
a medical demographic survey dataset is used as an example
to depict the process of converting data from a non-ontology
structure into a DO structure and further integration into the
TraM schema.
In this typical data translation workﬂow (Fig. 3), human
intervention usually occurs at an early stage of the dataﬂow.
Examples include ontology content development (concept
extraction and classiﬁcation) and data veriﬁcation (recovering
missing data and judging conﬂicting data). Reusable procedures,
such as data model conversion (transforming a set of data from
one-to-many relation into many-to-many relation), data matrix
transposition (changing columns to rows and vice versa), data
reformatting and sorting, and data deployment, are automated.
Some tasks, which also occur at an early stage of this dataﬂow,
need both human and computation interaction. Examples in-
clude tokenization and standardization of a free-text ﬁeld (de-
tailed in Section 6).Private 
SDBs
Data Translation
Account 
administrator Cura
Account admin 
module
Curatio
Module
Data 
Translation
Tool Kit
Tra
(Behin
TR
AM
 S
YS
TE
M
J
D
AT
A 
SO
U
R
C
E
EN
D
U
SE
R
S
SSH 
Fig. 4. System componen5. System
5.1. System components
The TraM system contains three major components (Fig. 4): (i) a
relational database supported by Oracle, (ii) a web-based applica-
tion system supported by Tomcat and (iii) a data translation toolkit
developed with various technologies. Currently, the ﬁrst two com-
ponents are being used directly by early-adopter translational
researchers, while the toolkit is prototyped and operated by
informaticians.
5.2. TraM database
5.2.1. Streamlined data coverage
If all the data from each and every domain in biomedical re-
search needed to be collected, a data integration project would be-
come almost impossible. Moreover, collecting every detail of a
patient’s medical records is usually unnecessary. Therefore, the
TraM data coverage is designed to keep the scope of data results-
driven and the information highly condensed. For example, the en-
tire specimen/tissue banking data are condensed into two entities:
specimen (unprocessed material from a human body: e.g., blood,
urine and solid tissues) and sample (processed material from a
specimen: e.g., DNA, RNA, parafﬁn-embedded tissue and cell lines).
Only the barcode of a sample and a few attributes (organ name and
sample name) are required. No operational details about the prep-
aration of samples are included in the TraM database and the stor-
age location of a sample is not required either. Required attributes
in the TraM schema were deﬁned based on discussions between
the TraM data model designer and biomedical research domain ex-
perts. Therefore, even though the TraM data cover extensive do-
main information, the scope of the data is slim and streamlined.
5.2.2. Data dependency control
To assure translational data continuity, we deﬁne a dependency
rule for research objects (Fig. 1) from a person to the samples de-Public 
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106 X. Wang et al. / Journal of Biomedical Informatics 42 (2009) 100–112rived from this person by foreign-key-not-null constraints. A bio-
sample without required person information will be rejected by
TraM. This rule ensures rigorous control over integrity and conti-
nuity of translational data.
5.2.3. Identifying HIPAA compliant data
The ability to track medical records and laboratory results to a
particular person adds great value to translational research
[6,7,9]. The TraM system creates a static ID for each person when
the uniqueness of the person is validated. This static ID functions
as a primary public ID to a person and is mapped to the original pa-
tient ID in the ‘‘person” physical table of the TraM database. How-
ever, all personal identiﬁable records are ﬁltered out (unlinked)
when a materialized view is created under a different user name
(an oracle concept). Both the materialized view and the entire
TraM schema are behind a ﬁre wall, while the query application
is restricted to interact only with the materialized view. Thus, per-
sonalized data can be identiﬁed through this public ID, but are still
de-identiﬁed to comply with HIPAA regulations [38]. This method
is relatively trivial in a data warehouse architecture, but can be
challenging to a query translation method to an interoperable data
integration system.
5.2.4. Terminology adoption and classiﬁcation
The TraM system avoids using locally invented terminology for
data descriptors. If the public domain provides reputable domain
ontologies or concept nomenclatures, the TraM system will adopt
these standards as valid terminology to describe the TraM data.
TraM preloads the concept descriptions and codes of International
Classiﬁcation of Disease (ICD) [39] for primary disease descrip-
tors, since this classiﬁcation system is used in many clinical SDBs
in the United States. As a research database, TraM also supports
NCI Thesaurus [35] and SNOMED-CT [40] nomenclatures and re-
lies on Uniﬁed Medical Language System (UMLS) [41] to map
SNOMED-CT and ICD concepts [42–44]. For the molecular biology
knowledge, TraM relies on hyperlinks to locate the updated and
detailed information in public knowledgebase through the Inter-
net. Examples include UniProt [30], Entrez Gene [31], OMIM
[34] and dbSNP [45].
For some research areas where no reputable nomenclatures are
available in the public domain, the TraM system provides prede-
ﬁned DO structure to assist researchers in creating their own con-
cept ontologies. For example, TraM provides DO structures for
medical demographic survey questionnaires and physical exam
names.
5.2.5. One schema for multiple medical specialties
It is unwise to build a speciﬁc database schema for each of dif-
ferent translational research projects. Such an approach is not only
costly for application development, but also troublesome for sys-
tem adoption and maintenance. In reality, although recruited re-
search domains vary in different translational research
workﬂows, many of them overlap. Furthermore, there is a strik-
ingly common logic of scientiﬁc conduct among a wide range of
translational workﬂows, though a given research project may have
domain usage preference (e.g., diabetes research more often fo-
cuses on results from metabolic laboratory tests, while cancer
may focus on pathology reviews). De-coupling unchanged data
structure (e.g., the three dimensional data point and translational
business logic ﬂow described in Fig. 1) from frequently changed
parameters (e.g., the actual research domains required in a partic-
ular research plan and domain scientiﬁc concepts and their
nomenclatures) reveals the feasibility of using one schema to sup-
port data from multiple medical specialties. In other words, the
application range of TraM is determined by the translational logic
ﬂow not the research subjects.5.3. TraM application system
Three types of application modules are designed in the applica-
tion layer to meet the speciﬁc goals of our project, and each type
has distinct architecture and logic control.
5.3.1. Account management module
As TraM is intended to support multiple topics of translational
research and allow curation for continuous data quality improve-
ment, data privacy and security control are necessary. The account
management module is designed to control data accessibility of
each project and to hide all HIPAA-protected information from reg-
ular users. These functions are implemented through a session
control mechanism. Four types of user roles are deﬁned under each
account and each type of role has different data accessibility. The
account administrator is an end user who is responsible for assign-
ing each of the other users a proper role based upon Institutional
Review Board (IRB) protocols. A graphical user interface (GUI) for
the account administrator was developed for this purpose
(Fig. 5). We assume account administrators know their colleagues
and collaborators better than a database administrator. The regular
user and power user have only ‘‘read” permission to query the TraM
data. The difference between them is that a power user (usually a
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lar user cannot. The curator (usually a data manager or someone
who has domain knowledge but does not directly conduct transla-
tional research) has both ‘‘read” and ‘‘write” permission and can
see HIPAA-protected information. The users in one account do
not have access to the data owned by other accounts unless per-
mission is granted by those account administrators. In addition,
the account management module maintains a user ID associated
activity log to record data manipulation history.
5.3.2. Curation modules
A conventional data warehouse usually does not provide a cura-
tor GUI. For a translational data integration system, where most
data come from heterogeneous sources with uneven qualities, data
curation is essential. The curation modules of different domains
share similar architectures and logical ﬂows. The curator GUI sup-
ports ‘‘read” and ‘‘write” abilities to facilitate data improvement.
With underlying data model support, curators are able to create
new concepts for a given domain when needed and use these con-
cepts to curate data immediately. Fig. 6 illustrates how a medical
survey questionnaire is deﬁned within a DO structure and how
such a questionnaire is instantly used to provide concepts for the
survey records. The underlying mechanism is to allow the new
question to play a double role: ﬁrst, as a record (value) in the ques-
tionnaire DO structure and second, as a question concept to survey
result. In this way, a curator gains enormous ﬂexibility in recruit-
ing new concepts within a predeﬁned data structure and in anno-
tating data with controlled vocabularies of this DO.
5.3.3. Query modules
The query modules are developed across research domains
based onmaterialized views and text indexmethods. De-identiﬁca-
tion is implemented in these modules for HIPAA compliance. To
make expressing queries intuitive to biomedical researchers, a
query-by-example (QBE) style GUI (Fig. 7) was used [46,47]. The
interface allows users to interactively select query ﬁlters, decide
‘‘and”, ‘‘or” and ‘‘not” conditions at each ﬁlter, execute query com-Fig. 6. Curator interface: (A) A curator can create new concepts within a predeﬁned ques
curate medical survey records.mands dynamically, and determine which data ﬁelds are to be dis-
played in a query return. Thus, one can query TraM data from any
point along an entire translational dataﬂow, and receive query re-
turns bi-directionally between research domains, from patient bed-
sides to experimental benches. Personalized data can be tracked
historically (retrospective and prospective data) and translationally
(across various research domains) through a primary person ID
(PubID, described in Section 5.2.3). The relevant public data can
be reached conveniently and efﬁciently through a URL. The normal-
ized data can be exported to Excel so the data are ready for statisti-
cal analysis or to exchange with other data management systems.
5.4. Data translation toolkit
The toolkit of TraM contains four kinds of utilities: (1) an online
data dictionary for TraM, (2) a set of data templates in table format
with predeﬁned domain concepts for requesting source data, (3) a
group of programs functioning as parsers and data model convert-
ers and (4) a set of SQL scripts for data deployment. These utilities
are developed for a typical data translation process (Fig. 3 of Sec-
tion 4.3). Many of them can be customized for various data integra-
tion projects. The data translation tools are not designed for a
special application area. Instead, they are built for manipulating
certain data structures, which can appear in many application
areas. The functions of these tools have been detailed in the Data
integration workﬂow (Section 4.3).
6. Case study
6.1. Data integration project overview
Data from 33,290 individuals under 22 IRB approved proto-
cols belonging to several translational research projects have
been used to assess TraM methods. The subjects of the research
include patients with head and neck, lung and breast cancers, as
well as non-malignant diseases, such as ataxia and irritable bo-
wel syndrome. All these projects are multi-institutional or inter-tionnaire ontology. (B) These questions and answer options can be used instantly to
Fig. 7. Query interface: (A) Data from a genetic epidemiology study in a cohort of Nigerians (detailed in Section 6); (B) Data from domestic patients. The results of (A and B)
are obtained by using different query ﬁlters and display options.
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of focus, and the data generated from these projects are at dif-
ferent stages of progress. Table 2 outlines the proﬁles of domain
data distributions, source data origins, and the data quality
descriptions (tokenization, normalization and standardization
levels) of these projects. Despite the diversity of research sub-
jects, we have not yet encountered a case that required us to
create a project-speciﬁc entity to meet its data integration de-
mand. All of these projects share a common logic as described
in Fig. 1, differing only in their domain activity preferences.
However, we have been constantly challenged with data hetero-
geneity from various research domains across the country and
world. Common problems resulting from this heterogeneity can
be summarized as the inconsistencies in concept extraction, data
modeling, and vocabulary used and the discontinuity of data de-
rived from the same cohort but collected in various research do-
mains. In the following discussions, we will use a real case to
detail how the TraM system is used to resolve these problems.
6.2. A use case
A genetic epidemiologic study of breast cancer is a typical trans-
lational research project that involves multiple research domains.
In this study data have been collected for more than 10 years from
a ﬁeld site in Ibadan, Nigeria. This data pool is only a small portion
of data in TraM’s ‘‘cancer genetics” account and is referred to as the
NG data. Table 3A summarizes the status of this data pool before
integration. It contains 20 segregated datasets in different storage
forms belonging to ﬁve research domains. Examples of these data-
sets include data from genetic epidemiologic surveys, specimen
banking, clinical diagnoses, pathology reviews, and genotyping
studies. Many records are generated in collaboration with scien-
tists in Nigeria. Even though the quantity of domain data in this
data pool is not huge, it is still extremely time consuming and labor
intensive for a researcher to track individuals’ data over different
source databases or datasets. The valuable information embedded
in this data pool therefore has not yet been fully extracted and
utilized. In order to effectively extract useful information fromthe NG data, we need ﬁrst to integrate these segregated datasets
so that researchers can search them undisturbed across different
domains.
6.3. Data curation and translation
It took a physician, a biologist, and a bioinformatician 2
months to complete the NG data integration. The physician,
who served the role of a curator, was responsible for verifying
clinical and pathology diagnostic data collected from Nigeria
and developing a questionnaire ontology for the survey data that
were stored in a locally developed ACCESS database. It took this
curator a dedicated 4 week period to build a genetic epidemiol-
ogy survey questionnaire in a DO structure required by the TraM
data model (Fig. 2B). As a result, the original ﬂat questionnaire
structure and loosely deﬁned survey responses were replaced
by consistent vocabularies and systematic organization. At this
stage, each new question is mapped to the old questions for data
integration purpose.
The old survey datawere collected frommultiple versions of a lo-
cally developedACCESSdatabase. Theywere allmapped to thenewly
deﬁned question answers and correspond to the deﬁnitions of ques-
tionnaire ontology. The same curator carried out this task to provide
the mapping table between the new answer and the old ones.
Simultaneously, the biologist, who also served as a curator, took
about 2 weeks to collect and verify the other domain data, which
included bio-specimens, DNA samples, and genotype records.
The rest of the procedures that are diagramed in Fig. 3 (Section
4.3) were computed. Most scripts developed in this process are
reusable with minor conﬁguration, regardless of source data ori-
gins. In particular, the scripts for converting and reassembling
survey data from a non-ontology structure to a DO structure have
been reused many times.
6.4. Integrated data
After integration, the integrity and continuity of NG data
were signiﬁcantly improved. A detailed assessment on these data
Table 2
Snapshot of data collected from translational research projects1
Domains covered in TraM Cancer genetics Breast SPORE Head & neck cancer Lung cancer IBS2 ATAXIA CIHDR3
Medical survey X (Genetic) X (Epidemiology) X (Environment) X (Trial follow up) X (Genetic) X (Social)
Demographics X X X X X X X
Family pedigree X X X
Physical exam X X
Clinical lab exam X X
Imaging exam X X X X X X
Clinical diagnosis X X X X X X X
Cancer staging X X X X
Metastasis X X
Pathological diagnosis X X X X X
Clinical treatment/trial X X X X X X
Medicine/chemo X X X X X X
Radiation X X X X X
Surgical X X X X X
Other X
Response evaluation X X X X X
Follow up X X
Adverse event X X
Biospecimen X X X X X
Biosample X X X X
Biomarker X X X
Basic research
Genotyping X X X
Other X
Data quality4
Tokenization +++ ++ ++ ++ + +++ ++
standardization + + + + + + +
TE exist +++ ++ + + +++ +++ ++
Data source5
Geographic location Domestic/foreign Domestic/foreign Cross institutes Cross institutes Foreign Cross institutes Domestic (regional)
Involved SDBsa 31 10 7 2 2 2 4
Storage formsb DBMS/excel/
paper
DBMS/excel/
paper
Excel Excel Excel/paper ACCESS/excel DBMS/excel/paper
1 The data presented in this table do not indicate complete data of the research plans nor imply all research activities of each of these projects: X, data presence; Null
(empty), data absence.
2 IBS (Irritable Bowel Syndrome).
3 CIHDR (Center for Interdisciplinary Health Disparities Research): This project shares a portion of data from the cancer genetics account.
4 Quality scale: ranging from ‘‘+” (lowest) to ‘‘+++++” (highest).
5 (a): Some projects have already collected data from different sources using ACCESS or Excel. We only count these secondary data sources and do not track the number of
original sources; (b): DBMS indicates any of the followings: Oracle, Cybase, MySQL, and ACCESS.
Table 3
Comparison of Nigerian (NG) data before and after curation and integration
Data ﬁelds A. Before curation and integration B: After curation and integration1
Persons Entries Storage forms Datasets Origin Integrated2 Included3 Recovered4 Excluded5
Person demographics 1577 1577 ACCESS; excel; paper 4 Nigeria 1577 1577 0 0
Case 905 981 Paper 1 Nigeria 1394 829 565 76
Specimen 210 1588 Excel; paper 3 Nigeria 1383 209 1174 1
Sample 1460 1447 Excel; paper 2 Nigeria 1379 1367 12 93
Epidemiology survey 591 106,019 ACCESS; excel; paper 3 Nigeria 591 591 0 0
Clinical diagnosis 637 637 Excel; paper 3 Nigeria 744 636 108 1
Pathology diagnosis 774 774 Excel; paper 3 United States 771 771 0 3
Genotype 814 15,010 Excel 1 United States 744 744 0 70
1 All the numbers in (B) are normalized to person counts: person counts listed in different data ﬁelds (rows) come from the same cohort and they are aligned to the same
persons across the ﬁelds. For example, the meaning of 744 person counts in genotype ﬁeld indicates that 744 persons out of 1577 persons who have demographics records
also have genotype records.
2 Integrated: person counts of each data ﬁeld of NG project in TraM, which are the sum of person counts from included and recovered columns.
3 Included: person counts of data from original source ﬁle, which should be equal or less than the counts in the Persons column of (A).
4 Recovered: person counts of data recovered during curation and integration process.
5 Excluded: person counts of data disqualiﬁed for TraM from source data ﬁle, which are the substraction of person counts in included column from the person counts in
persons column of (A). These data do not have any required sample donors’ information.
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normalized to person counts in comparison with the data before
curation and integration (in A). At this stage, the qualiﬁed NG
data from various domains are connected to each other. The
TraM curator GUI allows curators to further improve data from
this point. Integrated data in TraM allow researchers to effec-tively answer important translational research questions, such
as the question samples described in the Section 1. The informa-
tion extracted from the TraM data shown in Fig. 7 can now an-
swer these questions. The answers corresponding to each of the
questions are indicated within the parenthesis in the following
descriptions: Question 1 (Fig. 7A): how many patients (‘‘total re-
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diagnosed with cancer ‘‘A” (breast cancer) and had pathology re-
cords available (data in ‘‘histo_diagno” column), share a genetic
proﬁle ‘‘B” (alleles of UDP-glucuronosyltransferase (UGT) gene
in genotype column). Question 2 (Fig. 7B): which patients, who
were diagnosed with a special cancer type ‘‘C” (ductal carci-
noma) and had clinical treatment records ‘‘D” (chemo, surgical,
and radiation therapies and dates), share a distinct biomarker
‘‘E” (estrogen receptor positive) and have genetic pedigree maps
(progeny ﬁeld holds pedigree identiﬁers). Question 3 (Fig. 7A and
B): whether these patients have tissue or DNA samples available
(specimen and sample columns) and where these samples can be
obtained (the barcodes associated with samples) for further
studies. These results are normalized when exported in table for-
mat and ready for statistical analysis.
7. Discussion
7.1. Lessons learned in practice
7.1.1. Duration of a data integration process and members of a data
translation team
Duration of a data integration process varies depending upon
the involved research domains, data qualities (e.g., homogeneity,
standardization and tokenization status), knowledge and experi-
ence of curators, and thoroughness of a data integration plan.
Quantity of data usually does not have much impact on the dura-
tion of a data integration process. Homogeneous data integration
can be fully automated even if the size of the data is huge, such
as genotype data. The ability of converting source data in hetero-
geneous structures into TraM required conﬁgurations makes a
signiﬁcant difference in data translation efﬁciency. Handling this
process demands deep understanding of the nature and meaning
of the data, as well as computation knowledge. A best data trans-
lation team should include a dedicated biomedical informatician
(generic for all the projects) and one or two curators (project-spe-
ciﬁc, not necessarily full time) depending on the knowledge scope
required. With such a team, we are able to accomplish batch data
integration for the projects described in Table 2 within a time
span of a few weeks to 4 months. It is worthy of noting that this
calculation is based upon the ﬁrst round of data integration. Later
updates can be much more efﬁcient since the required domain
ontology has been established and the data translation tools can
be reused.
7.1.2. Recognize limitations of current technology and accept curator
role
Human intervention is needed to correct and improve trans-
lational data. The role of curator is often underestimated in grant
applications for both informatics and translational research. It is
unreasonable to expect that a substantial amount of free-text
data in clinical SDBs can be extracted, tokenized, and standard-
ized solely by a super smart ‘‘natural language processing” tool.
For example, a pure computation process (without a sophisti-
cated semantic mapping database) cannot ﬁgure out that the
text of ‘‘CHOP” in a chemotherapy free-text ﬁeld stands for
‘‘ADRIAMYCIN, CYCLOPHOSPHAMIDE, PREDNISONE, VINCRIS-
TINE” and that ‘‘MVAC” stands for ‘‘METHOTREXATE, VINBLAS-
TINE, ADRIAMYCIN, and CISPLATIN.” In our experience, it took
a curator 7 weeks of intensive effort to ﬁgure out 11,075 distinct
regimen records like these. After these records were standard-
ized and (computationally) sorted in alphabetical order, we
determined that these 11,075 distinct regimen records actually
only represent 206 types of chemotherapy drug combinations.
This is a typical example of how a curator plays a critical role
in a data integration process.In general, curators are typically responsible for the following
six tasks. (1) Identifying source data: A curator should be clear
which domain data are needed for a translational research plan.
(2) Identifying the data source: each translational research pro-
ject has its preferred collaborators so its data sources can be
in different institutions across the country or around the world.
A data integration system, such as TraM, can not predict or di-
rectly interact with those SDBs. (3) Recovering required missing
data: In reality, the majority of disparate domain SDBs do not re-
cruit data for a particular population in a synchronized manner,
nor are they necessarily designed to keep TE for other research
domains. It is very likely that data from different SDBs cannot
be integrated without human intervention. (4) Verifying contra-
dictory data: Data from different sources or versions of the same
source may conﬂict with each other in either expression or sub-
stance. To ensure reliability of records, curators need to resolve
such issues to the best of their knowledge. (5) Improving data
after integration: Typically, data still needs to be improved even
after integration, since some problems are often not detectable
when data are segregated but will be clearly revealed when data
are integrated. (6) Collaborating with programmers for process
automation.
7.2. Applications
The performance of the TraM system is independent of the SDB
environment since source data, not SDB interoperability, is the
only requirement for its functions. The system is best suited for re-
search that spans the bidirectional continuum between the bench
and the bedside. A unique aspect of this system is the integration of
basic science investigation with clinical trial data as well as medi-
cal (epidemiologic, genetic, environmental and social impact) ﬁeld
work questionnaires. In addition, it can be potentially applied to a
number of other purposes outlined below:
7.2.1. Monitor and manage research activity and plan for new studies
Data availability reﬂects research progress and activity. Being
able to monitor research activity through a single computational
platform will modernize research management and planning. Inte-
grated, continued, and veriﬁed biomedical data associated with
individuals allow researchers to more effectively discover underly-
ing scientiﬁc mechanisms and propose new aims or adjust meth-
odologies. In this sense, the TraM system may not only be a data
integration tool, but also a tool that facilitates data mining and re-
search planning.
7.2.2. Transform raw data into reliable knowledge
The knowledge that translational research reveals is precious
and evolving. Data always need to be revisited and updated when
a new discovery or interpretation emerges. With continuous cura-
tion and enrichment of information, reliable knowledge that data
represent is invaluable. Examples of transformation from a raw
data repository to a knowledgebase include GenBank to Entrez
Gene and PIR to UniProt. In these cases, curation activities behind
the scenes have been playing an important role in making this
transformation. The TraM system provides full-scale curation func-
tions so it can be potentially useful for a translational knowledge-
base construction.
7.2.3. Contribute to and beneﬁt from a service-oriented computation
network
The TraM system, after a service interface is enabled, can be a
key node from which to share of high-quality translational data
for an interoperable data grid. From another aspect, it can also ben-
eﬁt from this service-oriented grid to increase automation of the
data integration process.
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7.3.1. The system adoption relies on adopter’s data translation ability
We chose a data warehouse architecture to build the TraM
system for our intended goals. The system has been working
as we expected. Although the performance of the system is
SDB environment independent, it still relies on the informatics
expertise of the system adopters to translate data from sources
to TraM. This dependency may affect TraM’s adoption in all
institutions. We are in the process of improving the TraM data
translation toolkit and will eventually make the tools available
for the TraM adopters. We expect the toolkit will improve the
system adaptability but also realize the toolkit does not provide
plug and play functions. Informatics effort is needed to custom-
ize data translation tools for each set of special source data.
7.3.2. The ability to create a domain ontology may affect the clarity of
data concepts
Integration of DO structures into a typical ERM signiﬁcantly
boosts the data capture ﬂexibility, but it may also increase the
chances of recruiting inconsistent vocabulary and generating con-
cept/data redundancy (when the same concept is described by dif-
ferent vocabularies or vice versa). Even though only experienced
and knowledgeable curators are allowed to build concept for a
DO, domain experts and a nomenclature committee are eventually
required to align and improve the contents of DOs. The advantage
of TraM is that the data can be easily aligned to the improved DO
structure without going through data integration process again.
7.3.3. The traceability from the TraM data to source data
A physical copy of data in the TraM system allows data curation
and supports excellent query performance, but it may also be a lia-
bility for the system. In addition to lack of real-time information,
the integrated data, after being cleansed, veriﬁed, and standard-
ized, may look or actually be different from the source data. To
minimize this problem, TraM has developed a curation log and also
permanently stores the mapping records between the TraM PubID
and the HIPAA-protected identiﬁers behind a ﬁrewall to maintain
data traceability. However, since the source data in their original
format are mostly inaccessible due to HIPAA regulations, regular
TraM users are not able to view the original data as they exist
through hyperlinks, a convenience that most biological molecular
databases provide.
7.3.4. Not suitable for the demand of real-time data or domain-speciﬁc
operation
Although the TraM system is intended to support a wide
range of translational research, it is not recommended for real-
time data seekers or speciﬁc domain-limited investigators, since
the system does not directly interoperate with SDBs and largely
simpliﬁes domain operational details. Despite this, our stream-
lined data coverage approach is well matched to the needs of
translational researchers we have informally investigated.
8. Conclusion
This paper introduces a curation-enabled and warehouse-based
data integration strategy for translational research. It appears to be
a functioning and sustainable approach for translational research-
ers to manage and utilize their data. In years to come, currently
disconnected and non-transparent biomedical SDBs may undergo
an interoperable data sharing process and users may eventually
be able to successfully view various domain data from a uniﬁed
platform without migrating data. However, unless there is a mech-
anism to regulate the constituent SDBs so they can actively recruit
data for a particular translational research plan in a synchronizedmanner, the discontinuity, redundancy, and missing required data
elements and contents for targeted individuals will likely still oc-
cur. Therefore, with a service-enabled computation environment,
our system can work more efﬁciently to ensure high-quality of per-
sonalized translational data integration.Acknowledgments
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